Similar articles

• Clinical efficacy of grass-pollen immunotherapy.

  Longo G, Barbi E. Longo G, et al. N Engl J Med. 2000 Jan 6;342(1):58-9. N Engl J Med. 2000. PMID: 10627214 No abstract available.
• Clinical efficacy of grass-pollen immunotherapy.

  Ostergaard MS, Witt K. Ostergaard MS, et al. N Engl J Med. 2000 Jan 6;342(1):58; author reply 59. doi: 10.1056/NEJM200001063420112. N Engl J Med. 2000. PMID: 10627213 No abstract available.
• Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?

  Witten M, Malling HJ, Blom L, Poulsen BC, Poulsen LK. Witten M, et al. J Allergy Clin Immunol. 2013 Nov;132(5):1248-1252.e5. doi: 10.1016/j.jaci.2013.07.033. Epub 2013 Sep 13. J Allergy Clin Immunol. 2013. PMID: 24035151 No abstract available.
• Sublingual immunotherapy.

  Frew AJ. Frew AJ. N Engl J Med. 2008 May 22;358(21):2259-64. doi: 10.1056/NEJMct0708337. N Engl J Med. 2008. PMID: 18499568 Review. No abstract available.
• Antigen-specific immunotherapy against allergic rhinitis: the state of the art.

  Fujimura T, Okamoto Y. Fujimura T, et al. Allergol Int. 2010 Mar;59(1):21-31. doi: 10.2332/allergolint.09-RAI-0151. Epub 2010 Feb 25. Allergol Int. 2010. PMID: 20093851 Review.